Page 22 - Emergent Biosolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

State Roundup: Hogan launches new statewide vaxx initiative targeting seniors, college students, companies The State House in Annapolis (MarylandReporter.com file photo) HOGAN LAUNCHES NO ARM LEFT BEHIND VAXX INITIATIVE: Gov. Larry Hogan said Wednesday that the state is launching a new set of initiatives aimed at increasing access to coronavirus vaccines to seniors, college students and companies across Maryland, writes Bryan Renbaum of Maryland Reporter. “Today we are launching a series of No Arm Left Behind initiatives which will involve every state agency, private industries in every dem...

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of Emergent BioSolutions (NYSE:EBS) were falling 4% as of 11:07 a.m. EDT on Thursday after sinking as much as 7.6% earlier in the day. The stock tumbled earlier this week after the company was forced to halt production at its Bayview facility in Baltimor...

Apr 21, 2021 11:01am Among the issues cited by the FDA, Emergent failed to properly investigate an ingredient mix-up that cost the CDMO up to 15 million doses of Johnson & Johnson's COVID-19 vaccine. (Emergent) The FDA’s latest inspection of Emergent BioSolutions’ troubled Baltimore plant has raised fresh concerns about the contract manufacturer's ability to produce COVID-19 vaccines. Emergent, for its part, says it's working to get the plant up to speed. The regulator, which completed the inspection on Tuesday, cited Emergent for a raft of cleanliness and quality control issues, includi...

increase font size FDA report finds significant problems at Baltimore plant that contaminated J&J vaccine The new documents shed light into Emergent BioSolutions’ continued lack of federal authorization to distribute the vaccine it’s produced. By Hallie Miller and Meredith CohnThe Baltimore Sun Share A pharmacist holds a vial of the Johnson & Johnson COVID-19 vaccine at a hospital in Bay Shore, N.Y. On Wednesday, April 21, 2021, the Food and Drug Administration released a report saying the now-idle Emergent Biosciences factory where a key contractor hired to help make Johnson & Johnson�...

New global COVID cases just hit a record high (SPY -0.7%). Netflix stock down over 10% in late trading after quarterly results. Energy and financial sectors slide. The Market in Perspective Here are the headlines moving the markets. Why Dogecoin Wont Fall Into Bitcoins Energy Trap Dogecoin is ridiculous, and thats the whole point. The cryptocurrency that started out as a joke is now a meme come to very lucrative life, with nearly $50 billion worth of dogecoins in circulation today. In fact, the quirky cryptocurrency is red hot, and its value has skyrocketed more than 6,000% this year, maki...